Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umang Swami

Showing results (21-30 of 170) with videos related to

Pageof 17
Sort By:
JCO Oncology Practice|February 27, 2025
Challenges in the Management of Advanced Prostate CancerZeynep Irem Ozay, Umang Swami, Neeraj Agarwal
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2020
Quest for Ideal Composite Biomarkers for Response to ImmunotherapiesUmang Swami, Roberto H Nussenzveig, Neeraj Agarwal
Oncotarget|April 23, 2021
Immunotherapy and fatigue: what we know and what we don't knowMuhammad Azeem Khan, Vaia Florou, Umang Swami
European Urology|July 14, 2019
Characterizing the Wnt Pathway in Advanced Prostate Cancer: When, Why, and HowSumanta K Pal, Umang Swami, Neeraj Agarwal
JAMA Oncology|December 13, 2019
Radioisotope Imaging and Therapy for Bone Metastasis in Men With Castration-Resistant Prostate CancerUmang Swami, Jeffrey T Yap, Neeraj Agarwal
European Urology|January 9, 2021
Reply to Salma Kaochar, Nicholas Mitsiades' Letter to the Editor re: Umang Swami, Pedro Isaacsson Velho, Roberto Nussenzveig, et al. Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer. Eur Urol 2020, 78:652-6. Can Mutant SPOP Become an Actionable Biomarker for Precision Oncology Management of Prostate Cancer?: SPOP as a Potential Treatment Selection Marker in Prostate CancerUmang Swami, Emmanuel S Antonarakis, Neeraj Agarwal
JAMA Oncology|June 28, 2019
Ideal Glucocorticoid Regimen With Abiraterone Acetate: Options and ChallengesUmang Swami, Sumanta K Pal, Neeraj Agarwal
Genes|August 29, 2020
Harnessing DNA Replication Stress for Novel Cancer TherapyHuanbo Zhu, Umang Swami, Ranjan Preet, et al.
Oncotargets and Therapy|October 3, 2022
Clinical Evidence and Selecting Patients for Treatment with Erdafitinib in Advanced Urothelial CarcinomaNicolas Sayegh, Nishita Tripathi, Neeraj Agarwal, et al.
Case Reports in Oncological Medicine|April 10, 2019
Clinical Challenges with Talimogene Laherparepvec: Cured Lymph Nodes Masquerading as Active MelanomaUmang Swami, Brian Swick, Yousef Zakharia, et al.
Pageof 17

Showing results (21-30 of 170) with videos related to

Sort By:
Pageof 17
JCO Oncology Practice|February 27, 2025
Challenges in the Management of Advanced Prostate CancerZeynep Irem Ozay, Umang Swami, Neeraj Agarwal
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2020
Quest for Ideal Composite Biomarkers for Response to ImmunotherapiesUmang Swami, Roberto H Nussenzveig, Neeraj Agarwal
Oncotarget|April 23, 2021
Immunotherapy and fatigue: what we know and what we don't knowMuhammad Azeem Khan, Vaia Florou, Umang Swami
European Urology|July 14, 2019
Characterizing the Wnt Pathway in Advanced Prostate Cancer: When, Why, and HowSumanta K Pal, Umang Swami, Neeraj Agarwal
JAMA Oncology|December 13, 2019
Radioisotope Imaging and Therapy for Bone Metastasis in Men With Castration-Resistant Prostate CancerUmang Swami, Jeffrey T Yap, Neeraj Agarwal
European Urology|January 9, 2021
Reply to Salma Kaochar, Nicholas Mitsiades' Letter to the Editor re: Umang Swami, Pedro Isaacsson Velho, Roberto Nussenzveig, et al. Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer. Eur Urol 2020, 78:652-6. Can Mutant SPOP Become an Actionable Biomarker for Precision Oncology Management of Prostate Cancer?: SPOP as a Potential Treatment Selection Marker in Prostate CancerUmang Swami, Emmanuel S Antonarakis, Neeraj Agarwal
JAMA Oncology|June 28, 2019
Ideal Glucocorticoid Regimen With Abiraterone Acetate: Options and ChallengesUmang Swami, Sumanta K Pal, Neeraj Agarwal
Genes|August 29, 2020
Harnessing DNA Replication Stress for Novel Cancer TherapyHuanbo Zhu, Umang Swami, Ranjan Preet, et al.
Oncotargets and Therapy|October 3, 2022
Clinical Evidence and Selecting Patients for Treatment with Erdafitinib in Advanced Urothelial CarcinomaNicolas Sayegh, Nishita Tripathi, Neeraj Agarwal, et al.
Case Reports in Oncological Medicine|April 10, 2019
Clinical Challenges with Talimogene Laherparepvec: Cured Lymph Nodes Masquerading as Active MelanomaUmang Swami, Brian Swick, Yousef Zakharia, et al.
Pageof 17